2014 annual financial data
CRISPR Therapeutics 2014 Net margin
Direct answer
Net margin was Not calculable.
Operating income was -6,627,000 USD and net income was -6,800,000 USD.
Operating cash flow was -4,793,000 USD.
Get free CRISPR Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -6,627,000 USD
- Net income
- -6,800,000 USD
- Operating cash flow
- -4,793,000 USD